Other than the few medical centers who pioneered the migration to PACS, most hospitals lack the internal expertise to develop a comprehensive digital imaging business plan, create medical imaging architectures, select vendors, and implement PACS.Many
Other than the few medical centers who pioneered the migration to PACS, most hospitals lack the internal expertise to develop a comprehensive digital imaging business plan, create medical imaging architectures, select vendors, and implement PACS.
Many processes such as vendor selection and implementation are done only once, and developing such one-time experience in-house would be wasteful and inefficient, according to Wesley N. Bridgewater, senior business director in the department of radiology at Children's Hospital Medical Center (CHMC) in Cincinnati.
"It is highly unlikely that an inexperienced hospital-based group undertaking their first and only PACS project will be able to match the depth of a well-organized consulting group with prior experience," he said.
Before selecting a consultant, however, Bridgewater said the hospital needs to ask itself a few questions:
Then, once consultants are engaged, the organization can find ways to maximize effectiveness and minimize expense by following a few of the guidelines used by CHMC.
"Hospital leadership should dictate the consultants' mandate," Bridgewater said. "The organization must clearly state in writing its expectations of the consultant before work begins."
CHMC used the following rules of engagement during its consulting relationship with First Consulting Group:
Institutions are likely to find a relationship with a PACS consultant indispensable. Since PACS technology and industry alliances are constantly changing, consultants can energize a PACS project by providing unique resources, including deep installation expertise, a methodology for fast-tracking the initiative, and an address book bulging with industry contacts.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
Could an Emerging PET Tracer be a Game Changer for Detecting Hepatocellular Carcinoma?
June 23rd 2025In addition to over 90 percent sensitivity in detecting hepatocellular carcinoma (HCC), the glypican-3 (GPC3) targeted PET tracer 68Ga-aGPC3-scFv appeared to be advantageous in identifying HCC tumors smaller than one centimeter, according to pilot study findings presented at the SNMMI conference.
SNMMI: What a New Meta-Analysis Reveals About Radiotracers for PET/CT Detection of PCa
June 22nd 2025While (68Ga)Ga-PSMA-11 offers a pooled sensitivity rate of 92 percent for prostate cancer, (18F)-based radiotracers may offer enhanced lesion detection as well as improved imaging flexibility, according to a meta-analysis presented at the Society for Nuclear Medicine and Molecular Imaging (SNMMI) conference.